General methods for compound purification and characterization
Chemicals were purchased and used without further purification. 1 H NMR and 13 C NMR spectra were recorded on 800 MHz Bruker Avance III spectrometers. High resolution electrospray ionization (ESI) mass spectra were obtained using Thermo Electron LTQ-Orbitrap Hybrid MS at the Mass Spectrometry Facility in the University of California, Davis. Silica gel 60 Å (230-400 mesh, Sorbent Technologies) was used for flash column chromatography. RediSep ® R f C18 Aq Gold cartridges were bought from Teledyne Isco Inc .Thin-layer chromatography (TLC, Sorbent Technologies) was performed on silica gel plates using anisaldehyde sugar staining or 5% sulfuric acid in ethanol staining for detection. Phytoshingosine was purchased from TCI America. DGalactose (Gal) and N-acetyl-D-glucosamine (GlcNAc) were purchased from Fisher Scientific (Pittsburgh, Pennsylvania, USA. Guanidine 5'-triphosphate (GTP) was bought from Hangzhou Meiya Pharmacy (Hangzhou, China). Adenosine 5'-triphosphate (ATP) was bought from Beta Pharma Scientific, Inc (Branford, CT). Uridine-5'-triphosphate (UTP) was bought from Chemfun Medical Technology Co. Recombinant enzymes Streptococcus pneumoniae TIGR4 galactokinase (SpGalK), 1 Pasteurella multocida N-acetylglucosamine uridyltransferase (PmGlmU), 2 Bifidobacterium longum strain ATCC55813 N-acetylhexosamine-1-kinase (BiNahK), 3 Pasteurella multocida inorganic pyrophosphatase (PmPpA), 4 Neisseria meningitides 1-3-Nacetylglucosaminyltransferase (NmLgtA), 5 Bifidobacterium longum UDP-sugar pyrophosphorylase (BLUSP), 6 bovine 1-3-galactosyltransferase (B1-3GalT), 7 Neisseria meningitidis 1-4-galactosyltransferase (NmLgtB) 4 were expressed and purified as described previously. One unit (U) is defined as the amount of the enzyme that catalyzes the conversion of 1 mol of substrate per minute at 30 C for NmLgtA or 37 C for all other enzymes.
(2R,3R,4E)-2-Azido-3-O-benzoyloxy-1-O-tertbutyldiphenylsilyloxy-octadec-4-ene (11) 8
Compound 10 was synthesized from commercially available phytosphigosine (6) as reported previously. 9 For the synthesis of compound 11, to a solution of compound 10 (3.9 g, 6.9 mmol) in dry CH 2 Cl 2 (25 mL), Et 3 N (5.8 mL, 41.4 mmol) and 4-dimethyl amino pyridine (DMAP) (0.84 mg, 0.69 mmol) were added and the mixture was stirring at 0 °C. Benzoyl chloride (1.6 mL, 13.8 mmol) was then added to the stirring reaction mixture drop-wisely. The reaction was allowed to warm up to r.t. and stirred for overnight, until TLC analysis (hexane:ethyl acetate = 9:1 by volume and detected with p-anisaldehyde sugar stain) showed total consumption of the starting material. The reaction was then diluted with CH 2 Cl 2 , washed with HCl (1 N), saturated NaHCO 3 solution, and brine (10% NaCl solution), and was dried with Na 2 SO 4 . After filtration, the solvent was removed under reduced pressure and the product was purified by silica gel chromatography using hexane:EtOAc = 20:1 (by volume) as an eluent to produce compound 11 (4.3 g, 95%) as a colorless oil. 1 To a solution of compound 11 (3.75 g, 5.61 mmol) in dry THF (40 mL) in a plastic flask, 65-70% HFpyridine solution (1.8 mL) was added drop-wisely to the stirred mixture at 0 C. The reaction mixture was stirred at r.t. for about 4 h until complete consumption of compound 11 as judged by TLC analysis (hexane:ethyl acetate = 8:1 by volume and detected with p-anisaldehyde sugar stain). The reaction mixture was then quenched using solid NaHCO 3 . EtOAc (50 mL) and H 2 O (50 mL) were then added. The aqueous phase was extracted twice with EtOAc. The combined organic phase was washed with a saturated aqueous solution of NaHCO 3 and dried over Na 2 SO 4 . After filtratrion, the solvent was removed under reduced pressure and the product was purified by silica gel chromatography using hexane:EtOAc = 6:1 (by volume) as an eluent to produce compound 12 (2.3g, 97%) as a off-white residue. 1 
O-(2,3,4,6-Tetra-O-benzoyl--D-galactopyranosyl)-(14)-(2,3,6-tri-O-benzoyl--Dglucopyranosyl)-(11)-(2S, 3R, 4E)-2-azido-3-O-benzoyloxy-octadec-4-ene (14) 10
To a solution of perbenzoylated lactosyl trichloroacetimidate 13 (1.1 g, 0.90 mmol) 10 and acceptor 12 (300 mg, 0.69 mmol) in 25 mL of dry CH 2 Cl 2 , powdered molecular sieves (4Å, 1.0 g) were added. The mixture was stirred under argon at r.t. for 30 min. The reaction mixture was cooled down to -18 °C and BF 3
. OEt 2 (377 µL, 1.0 mmol) was added. The reaction mixture was then stirred at -20 °C until TLC analysis (hexane:ethyl acetate = 3:1 by volume and detected with panisaldehyde sugar stain) showed fully conversion of the acceptor (30-45 min). The reaction was quenched with Et 3 N, and the solid was filtered off. The filtrate was concentrated under vacuum, and the residue was purified by silica gel chromatography using hexane:EtOAc = 3:1 (by volume) as an eluent to produce compound 14 (930 mg, 90%) as a colorless oil. 1 
Gram-scale synthesis of LacSph (5): O-(-D-galactopyranosyl)-(14)-(-D-glucopyranosyl)-(11)-(2S, 3R, 4E)-2-aminooctadec-4-ene-1,3-diol (5) 11

S4
To a solution of 14 (2.9 g, 1.95 mmol) in dry MeOH (50 mL), NaOMe (250 mg) was added. After being stirred at r.t. for 6 h, the reaction mixture was neutralized with Dowex 50W (H + ), filtered and concentrated under reduced pressure. This intermediate was used in the next step without further purification. To the dry intermediate (1.25 g, 1.92 mmol) in pyridine-water (1:1 v/v, 30 mL), 1,3-propanedithiol 12 (1.9 mL, 19 mmol) and Et 3 N (2 mL) were added and the mixture was stirred at 50 °C for 48 h. The reaction mixture was concentrated and purified by silica gel chromatography using chloroform:methanol:water (5:4:1 v/v/v) as an eluent to produce compound 5 (1.10 g, 94%) as a white amorphous powder. 1 
One-pot four-enzyme synthesis of Lc 3 Sph (4): O-(2-acetamido-2-deoxy--D-glucopyranosyl)-(13)-(-D-galactopyranosyl)-(14)-(-D-glucopyranosyl)-(11)-(2S, 3R, 4E)-2-aminooctadec-4-ene-1,3-diol (4)
To prepare the trisaccharide 4, NmLgtA (0.5 mg, 0.29 U/mg when LacMU was used as the acceptor substrate) 5 was added to a centrifuge tube (10 mL) containing 25 mg of LacSph (5), GlcNAc (1.2 eq., 10 mg), ATP (1.5 eq., 33 mg), UTP (1.5 eq, 30 mg.), MgCl 2 (20 mM), Tris-HCl buffer (100 mM, pH = 8.0), BiNahK (0.7 mg, 1.4 U/mg when GlcNAc was used as the substrate), 3 PmGlmU (1.25 mg), PmPpA (1 mg), and water. The total volume was brought up to 9.5 mL. The reaction mixture was incubated at 37C for 52 h. The reaction progress was monitored using mass spectrometry and TLC (CHCl 3 :MeOH:H 2 O = 5:4:1, by volume). After the reaction reached to an optimum yield, reaction mixture was diluted with the same volume of ethanol and the solution was incubated at 4 °C for 30 min. The precipitates were removed by centrifugation and the supernatant was concentrated. The residue was dissolved in 2-3 mL of water at 40-45 °C and the solution was directly loaded to a preconditioned RediSep ® R f C18 cartridge (5.5 g media) through a 10 mL plastic syringe. After loading, the cartridge was washed with acidic deionized water (10 mL with 0.01% TFA v/v) to wash out non-lipid components. The product was eluted from the C18 cartridge with 37% acetonitrile and 0.01% TFA in water (v/v). The elute solvent was collected in 1-1.5 mL fractions. Unreacted LacSph was eluted with 50% acetonitrile in 0.01% TFA/H 2 O. The whole process took 20-30 minutes. The target glycolipid 4 (27 mg, 83%) was isolated after lyophilization. 1 
One-pot four-enzyme synthesis of nLc 4 Sph (3): O-(-D-galactopyranosyl)-(14)-(2-acetamido-
2-deoxy--D-glucopyranosyl)-(13)-(-D-galactopyranosyl)-(14)-(-D-glucopyranosyl)-(11)-(2S, 3R, 4E)-2-aminooctadec-4-ene-1, 3-diol (3) 13
To prepare the tetrasaccharide 3, NmLgtB (0.3 mg, 0.07 U/mg when GlcNAcMU was used as the acceptor substrate) 4 was added to a centrifuge tube (10 mL) containing 20 mg of the trisaccharide acceptor 4, Gal (1.2 eq., 5 mg), ATP (1.5 eq., 20 mg), UTP (1.5 eq., 18 mg), MgCl 2 (20 mM), Tris-HCl buffer (100 mM, pH = 8.0), SpGalK (0.40 mg), BLUSP (0.5 mg, 56 U/mg when glucose-1-phosphate was used as the substrate), 1 PmPpA (0mg) and water. The total volume was bought up to 6 mL. The reaction mixture was incubated at 37 C for 30 h. The reaction progress was monitored using mass spectrometry and TLC (CHCl 3 :MeOH:H 2 O = 5:4.5:1.5). After the reaction was reached to an optimum yield, reaction mixture was diluted with the same volume of ethanol and incubated at 4 °C for 30 min. The precipitates were removed by centrifugation and the supernatant was concentrated. The residue was dissolved in 2-3 mL of water at 40-45 °C. Then the solution was directly loaded to a preconditioned RediSep ® R f C18 cartridge (5.5 g media) through a 10 mL plastic syringe and washed with acidic deionized water (10 mL with 0.01% TFA v/v) to wash out non-lipid components. The elute solvent was collected in 1-1.5 mL fractions. The product was eluted from the C18 cartridge with 35% acetonitrile and 0.01% TFA in water (v/v).The whole process takes about 20-30 minutes. The target glycolipid 3 (22 mg, 92%) was obtained as white powder after lyophilization. 1 
One-pot four-enzyme synthesis of Gal3nLc 4 Sph (2): O-(-D-galactopyranosyl)-(13)-(-Dgalactopyranosyl)-(14)-(2-acetamido-2-deoxy--D-glucopyranosyl)-(13)-(-Dgalactopyranosyl)-(14)-(-D-glucopyranosyl)-(11)-(2S, 3R, 4E)-2-aminooctadec-4-ene-1,3-diol (2) 14
To prepare the pentasaccharide 2, B1-3GalT (0.3 mg, 10.6 U/mg when lactose was used as the acceptor substrate) 7 was added to a centrifuge tube (10 mL) containing 12 mg of the tetrasaccharide acceptor 3, Gal (1.2 eq., 3 mg), ATP (2 eq., 14 mg), UTP (2 eq., 12 mg), MgCl 2 (20 mM), MnCl 2 (20 mM), Tris-HCl buffer (100 mM, pH = 7.5), SpGalK (0.6 mg), BLUSP (0.9 mg, 56 U/mg when glucose-1-phosphate was used as the substrate), 1 PmPpA (mg) and water. The total volume was bought up to 3 mL). The reaction mixture was incubated at 37 C for 48 h. The reaction progress was monitored using mass spectrometry and TLC (CHCl 3 :MeOH:H 2 O = 5:4.5:1.5, by volume). After the reaction was reached to an optimum yield, reaction mixture was diluted with the same volume of ethanol and incubated at 4 °C for 30 min. The precipitates were removed by centrifugation and the supernatant was concentrated. The residue was dissolved in 2-3 mL of water at 40-45 °C. Then the solution was directly loaded to a preconditioned RediSep ® R f C18 cartridge (5.5 g media) through a 10 mL plastic syringe and washed with acidic deionized water (10 mL with 0.1% TFA v/v) to wash out non-lipid components. The elute solvent was collected in 1-1.5 mL fractions. The product was eluted from the C18 cartridge with 32% acetonitrile in 0.1% TFA/water (v/v) and the unreacted acceptor was eluted using 35% or a higher concentration (50%) of acetonitrile in 0.1% TFA/H 2 O. The whole process took about 20-30 minutes. The target glycolipid 2 (12.8 mg, 88%) was obtained after lyophilization. 1 
Synthesis of Gal3nLc 4 Cer (1): O-(-D-galactopyranosyl)-(13)-(-D-galactopyranosyl)-(14)-(2-acetamido-2-deoxy--D-glucopyranosyl)-(13)-(-D-galactopyranosyl)-(14)-(-D-glucopyranosyl)-(11)-(2S, 3R, 4E)-2-(hexadecaneacetamido)-octadec-4-ene-1, 3-diol (1)
To a solution of sphingolipid 2 (8 mg, 0.007 mmol) in dry DMF (1 mL), HOBt (1.5 mg, 0.009 mmol), EDC . HCl (1.6 mg, 0.009 mmol), palmitic acid (2.2 mg, 0.009 mmol), and Et 3 N (105 mL, 0.01 mmol) were added to the solution. The reaction mixture was stirred under N 2 atmosphere at room temperature for 24 h. The reaction progress was monitored using mass spectrometry. After completion, the solution was concentrated under reduced pressure and passed through Sephadex™ LH 20 using CH 3 OH) as eluant to produce pure compound 1 (8 mg, 85%). 1 
